Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Insomnia can predict the appearance of back pain in adults

  • Parkinson's: Small molecules researched for the regeneration of dopaminergic neurons

  • Why some antidepressants may initially worsen symptoms

  • Autism, intellectual disability studied in quest for new treatment approaches

  • Tackling neurotransmission precision

  • Of bugs and brains: Striking similarities in brain structures across invertebrates

  • Neuro-oncologists discover cancer cells can burn acetate for fuel

  • Parkinson's disease reverted at experimental stage

  • The dementia that is not Alzheimer's disease

  • First successful vaccination against 'mad cow'-like wasting disease in deer

  •